Skip to main content

Health & Veritas: Scoring the Ethics of Pharma Companies (Ep. 42)

On the Health & Veritas podcast, Yale physician-professors Howard Forman and Harlan Krumholz talk about the latest news and ideas in healthcare and seek out the truth amid the noise. In this episode, they discuss Harlan’s large new study tracking the trajectory of patient safety in hospitals, and consider how individuals should respond to the latest COVID-19 variants. And they’re joined by Jennifer Miller, a Yale bioethicist and the director of the Good Pharma Scorecard, which evaluates the performance of pharmaceutical companies on measures like the transparency of clinical trials and the accessibility of medicines.

Jennifer Miller
  • Howard P. Forman
    Professor of Radiology and Biomedical Imaging, Economics, Public Health, and Management; Co-founder, Pozen-Commonwealth Fund Fellowship in Health Equity Leadership, MD/MBA Program, and MBA for Executives Program
  • Harlan M. Krumholz
    Harold H. Hines, Jr. Professor of Medicine and Director of the Yale Center for Outcomes Research and Evaluation
  • Jennifer Miller
    Associate Professor, Yale School of Medicine; President, Bioethics International; Founder, Good Pharma Scorecard

Listen now:

Links

“New Federal Study Evaluates the Safety of US Hospitals and the Answer Is…”

“Trends in Adverse Event Rates in Hospitalized Patients, 2010-2019”

Good Pharma Scorecard

Learn more about the MBA for Executives program at Yale SOM.

Email Howie and Harlan comments or questions.

Subscribe to Health & Veritas in Apple Podcasts, Spotify, Google Podcasts, or your favorite podcast player.

A "Health & Veritas" logo